Abstract: Fatty acid biosynthesis is catalyzed in most bacteria by a group of highly conserved proteins known as the type II fatty acid synthase (FAS II) system. FAS II has been extensively studied in the Escherichia coli model system, and the recent explosion of bioinformatic information has accelerated the investigation of the pathway in other organisms, mostly important human pathogens. All FAS II systems possess a basic set of enzymes for the initiation and elongation of acyl chains. This review focuses on the variations on this basic theme that give rise to the diversity of products produced by the pathway. These include multiple mechanisms to generate unsaturated fatty acids and the accessory components required for branched-chain fatty acid synthesis in Gram-positive bacteria. Most of the known mechanisms that regulate product distribution of the pathway arise from the fundamental biochemical properties of the expressed enzymes. However, newly identified transcriptional factors in bacterial fatty acid biosynthetic pathways are a fertile field for new investigation into the genetic control of the FAS II system. Much more work is needed to define the role of these factors and the mechanisms that regulate their DNA binding capability, but there appear to be fundamental differences in how the expression of the pathway genes is controlled in Gram-negative and in Gram-positive bacteria.
The basic type II fatty acid biosynthetic pathway
Fatty acids are not only one of the major components of cell membrane but also metabolic intermediates in bacteria. In most bacteria, a type II fatty acid synthase (FAS II) system is used for de novo fatty acid biosynthesis. Different from the mammalian type I system, which uses a large multifunctional enzyme, the type II system uses a series of monofunctional proteins, and each catalyzes one step in the biosynthesis pathway. This system has been investigated extensively in an Escherichia coli model system (for reviews, see Cronan and Rock 1996; Rock and Cronan 1996; Jackowski and Rock 2002) , and the enzymes are highly conserved in most bacteria. The primary destinations for bacterial fatty acids are membrane phospholipids and lipopolysaccharides, and the structures of the fatty acid components of the membrane lipids are a primary determinant of the membrane's biophysical properties. This review focuses on the mechanisms utilized by bacteria to modulate the product distribution of the type II pathway. The synthesis and function of bacterial membrane phospholipids are covered in a recent review by , and lipopolysaccharide biosynthesis is covered by Raetz and Whitfield (2002) .
The components of fatty acid biosynthesis are identified by a capital letter following the abbreviation for either the gene (fab) or the protein (Fab), and the basic protein set required to synthesize a fatty acid is shown in Fig. 1 . A key feature of this system is that all fatty acyl intermediates are covalently connected with a small acidic protein, acyl carrier protein (ACP), and shuttled from one enzyme to another. Fatty acid biosynthesis begins at the acetyl-CoA carboxylase, a heterotetrameric enzyme encoded by four genes, accABCD. The substrate acetyl-CoA is converted to malonyl-CoA and the malonate group is transferred to ACP by malonyl-CoA:ACP transacylase (FabD) to form malonyl-ACP. A condensation of malonyl-ACP with acetyl-CoA by β-ketoacyl-ACP synthase III (FabH) to form β-ketobutyryl-ACP and CO 2 initiates a cycle that can elongate the fatty acyl-ACP by two carbon units for each cycle until a saturated fatty acid (SFA) of 16 or 18 carbons is made. The first reaction in this cycle is the NADPH-dependent reduction of β-ketoacyl-ACP to β-hydroxyacyl-ACP by β-ketoacyl-ACP reductase (FabG) , and then the β-hydroxyl intermediate is dehydrated to yield trans-2-enoyl-ACP catalyzed by either β-hydroxydecanoyl-ACP dehydratase/isomerase (FabA) or β-hydroxyacyl-ACP dehydratase (FabZ). The last step of the cycle is the NAD(P)H-dependent reduction of the double bond in the trans-2-enoyl-ACP intermediate by an enoyl-ACP reductase (enoyl-ACP reductase I (FabI), enoyl-ACP reductase II (FabK), or enoyl-ACP reductase III (FabL)) to form an acyl-ACP. Either β-ketoacyl-ACP synthase I (FabB) or β-ketoacyl-ACP synthase II (FabF) initiates the subsequent elongation cycles by condensation of malonyl-ACP with the acyl-ACP. All type II synthases have this basic set of enzymes to initiate and elongate acyl chains, and the diversity of products is achieved by variations on this theme.
Control of fatty acid chain length
The condensing enzymes are important determinants of the product distribution of the fatty acid biosynthetic pathway. In E. coli, FabB is essential for unsaturated fatty acid (UFA) biosynthesis (Cronan et al. 1969; D'Agnolo et al. 1975) , and the level of fabB expression determines the UFA to SFA ratio Zhang et al. 2002) . FabF is an intrinsically temperature-sensitive (Ts) enzyme and accounts for the thermal regulation of membrane fatty acid composition (Garwin et al. 1980b; . Although the substrate specificity of the synthases is the most important determinant of the chain length of fatty acid produced by the pathway, the observed composition arises in part from the competition between the rate of elongation of long-chain acyl-ACP and the rate of its utilization by glycerol-3-phosphate acyltransferase (PlsB) (Cronan et al. 1975 ). Many pathogens have only a single condensing enzyme, usually classified as a FabF, and most organisms produce 16-and 18-carbon fatty acids. The chain length substrate specificity of the condensing enzymes is understood through the analysis of the acyl-enzyme binding pocket in crystal structures, which appears to be capable of accommodating no more than 16 carbons (Huang et al. 1998; Moche et al. 1999 Moche et al. , 2001 Price et al. 2001 Price et al. , 2003 ; Fig. 1 . Type II fatty acid biosynthesis pathway. First, acetyl-CoA is carboxylated by the four subunits of AccABCD to form malonylCoA, which is then transferred to ACP by FabD. Cycles of fatty acid elongation are initiated by the condensation of acetyl-CoA with malonyl-ACP catalyzed by FabH. The second step in the elongation cycle is carried out by FabG. The β-hydroxyacyl-ACP intermediate is dehydrated by either FabA or FabZ to form trans-2-enoyl-ACP. The final step of elongation is catalyzed by enoyl-ACP reductase, and three forms of this enzyme are known (FabI, FabK, and FabL) . Subsequent rounds of elongation are initiated by the elongation condensing enzymes (FabB and FabF) until the final products are formed. Olsen et al. 2001) . Thus, the size of the acyl-enzyme intermediate binding site on the condensing enzymes establishes an upper limit to the chain lengths that can be produced by FAS II systems.
Some bacteria synthesize unusually long acyl chains. The most notable organism is Mycobacterium tuberculosis, where the type II system produces very-long-chain mycolic acids. Two components are required. First, the two condensing enzymes in this organism (KasA and KasB) are thought to have unique substrate binding pockets that allow the formation of longer chain acyl-enzyme intermediates. However, there is little experimental evidence to support this idea due to the lack of techniques to produce substrates of the appropriate length. Thus, the high-resolution structures of KasA and KasB are needed to determine if the acyl chain binding pocket of these enzymes is significantly different from that of the condensing enzymes involved in making 16-and 18-carbon fatty acids. The second component that is required is a special ACP. These ACPs are characterized as having long carboxy terminal extensions that are postulated to be involved in the binding of the long acyl chains to the carrier protein (Kremer et al. 2001; Schaeffer et al. 2001; Brozek et al. 1996) . However, the structure of the M. tuberculosis AcpM has been solved and the carboxy terminal extension exists as a random coil (Wong et al. 2002) . Further structural studies on long-chain acyl groups attached to these specialized ACPs will be needed to test the hypothesis for the role of the carboxyl terminal domain in lipid binding.
Genes required for UFA biosynthesis
FAS II produces UFA by introducing the cis double bond into the growing acyl chain. Unlike the desaturases of mammalian cells, which introduce double bonds into the completed fatty acid chains, the FAS II system functions both aerobically and anerobically, since it does not require molecular oxygen. In organisms that produce straight-chain fatty acids, the percentage of UFA produced is the major determinant of membrane fluidity and function (Cronan and Vagelos 1972) ; and accordingly, UFA synthesis is an essential facet of bacterial physiology that has been intensively investigated. Two genes, fabA and fabB, are the key players in this pathway, and fabA and fabB occur together in bacteria that produce UFA. In some organisms, for example Pseudomonas aeruginosa, fabA and fabB are cotranscribed in a fabA-fabB operon (Hoang and Schweizer 1997) . These players in E. coli UFA synthesis were defined by the isolation and characterization of UFA auxotrophs (Silbert and Vagelos 1967; Cronan et al. 1969) followed by the purification and characterization of the gene products (Kass and Bloch 1967; D'Agnolo et al. 1975; Garwin et al. 1980a; Bloch 1968 (Fig. 2) . Although the isomerization activity is absolutely essential for double bond formation, FabA does not catalyze the rate-limiting step in UFA formation, but rather, the activity (expression level) of FabB is the determining factor for cellular UFA content Cronan et al. 1969; Zhang et al. 2002) . In fabB mutants, SFA synthesis persists because of the presence of the other elongation condensing enzyme in E. coli, FabF (D'Agnolo et al. 1975; Garwin et al. 1980a ). The inability to support UFA synthesis in fabB mutants leads to Rock and Cronan 1996) . Paradoxically, FabF is capable of functioning in UFA synthesis in vitro (C.O. Rock, unpublished information) , and several organisms with UFA have only a FabF type of enzyme (see below), suggesting that a requirement for FabB in the elongation of UFA is not absolute. Escherichia coli fabF mutants lack 18:1 fatty acids (Gelmann and Cronan 1972; Garwin et al. 1980a ), leading to the conclusion that FabF, and not FabB, is capable of elongating 16:1 to 18:1. However, the derepression of fabB expression by inactivation of the fatty acid biosynthesis regulator (FabR) repressor or the overexpression of FabB directed by a plasmid ) results in the accumulation of 18:1 fatty acids even in the absence of fabF expression. Therefore, the substrate specificities of the condensing enzymes are not absolute, but rather, the functions of the enzyme assigned by genetic analysis arise from a combination of their substrate preferences, expression levels, and competitive interactions with other FAS II components.
FabA and FabB are not widely distributed in bacteria (Campbell and Cronan 2001a) , and a bioinformatics analysis of the available genomic data indicates that the FabA/FabB pathway for UFA synthesis may be restricted to alpha and gamma proteobacteria. However, some Gram-positives like streptococci and clostridia, which lack a fabA or fabB homolog, produce UFA. Recently, a new pathway for UFA was discovered in Streptococcus pneumoniae , which has a fatty acid composition that is almost identical to that of E. coli. Interestingly, all of the fatty acid biosynthesis enzymes are located in a single cluster in S. pneumoniae (Tettelin et al. 2001; Sunohara et al. 2001) . There is no FabA homolog, and the FabZ dehydratase in this organism only carries out the dehydration reaction. The search for another S. pneumoniae enzyme able to divert the fatty acid synthesis to the unsaturated branch led to the discovery of a novel enzyme, trans-2, cis-3 enoyl-ACP isomerase (FabM) . FabM is the first gene in the FAS II cluster and is most closely related to the isomerases in fatty acid β-oxidation. Streptococcus pneumoniae is an anaerobe and does not posses a fatty acid β-oxidation enzyme set. Thus, the branch point in UFA synthesis occurs one step downstream in the FAS II of S. pneumoniae compared with E. coli. After the formation of trans-2-enoyl-ACP catalyzed by FabZ, FabM isomerizes trans-2-decenoyl-ACP to cis-3-decenoyl-ACP, which introduces a double bond into the growing acyl chain. FabF carries out the elongation of both saturated and unsaturated acyl-ACPs (Fig. 2) . The competitive partners at the branching point are FabK and FabF, in contrast with the competition between FabI and FabB in E. coli.
The FabK/FabM mechanism seems specific for streptococci because the analysis of genomes of other species does not reveal the presence of a FabM analog. Enterococcus faecium has two Fab clusters in its genome (Paulsen et al. 2003) . One is similar to the S. pneumoniae cluster except it is missing FabM. The second cluster contains three genes: fabI, fabZ, and fabF. An attractive hypothesis for UFA synthesis in Enterococcus is that these three genes function in the same way as the FabI, FabA, and FabF genes do in E. coli. One certainly would not predict that the fabZ gene in this cluster would encode an enzyme with isomerase activity, but we know so little about the structure determinants for the isomerase reaction that current bioinformatics tools may be misleading. The structure of FabA has been solved (Leesong et al. 1996) , but a FabZ structure coupled with a detailed mutagenesis and biochemical study is needed before we will have the information required to pinpoint the residue(s) essential for isomerase activity. Likewise, the fabF in this cluster definitely falls in the F rather than B cluster of condensing enzymes, but as mentioned above, the FabF protein is capable in vitro of elongating UFA, opening the possibility that the fabF in this three-gene cluster functions in UFA production. Another Gram-positive bacterium, Clostridium acetobutylicum, does not contain FabA, FabM, or a second I-Z-F gene cluster (Xu et al. 2003) , and thus, there is a new mechanism for UFA synthesis remaining to be discovered in this group of bacteria.
Another pathway of UFA synthesis in bacteria is aerobic desaturation. These enzymes are not part of FAS II, but rather, desaturate existing fatty acids attached to membrane phospholipids. The investigation of this system by the de Mendoza laboratory shows that these desaturases are found in bacilli and cyanobacteria (Campbell and Cronan 2001a) . In Bacillus subtilis, the fatty acyl-desaturase (Des) is a ∆5 desaturase ) and can be induced by cold shock (Mansilla et al. 2003; Cybulski et al. 2002; Aguilar et al. 1998) . A two-component signal transduction system, DesK-DesR, regulates the expression of the desaturase (Aguilar et al. 1999 (Aguilar et al. , 2001 ). This mechanism for postbiosynthetic modification of membrane phospholipid biophysical properties is thought to allow B. subtilis to adapt to an abrupt downshift of temperature.
Origin of ␤-hydroxy fatty acids
A major fatty acid produced by the E. coli FAS II is β-hydroxymyristate, which is the primary fatty acid of the lipopolysaccharides that reside on the outer leaflet of the outer membrane of Gram-negative bacteria (Raetz and Whitfield 2002) . The mechanism for the formation of this fatty acid is straightforward. β-Hydroxymyristoyl-ACP is a normal intermediate in the FAS II elongation cycle, and bacteria that incorporate this fatty acid into their membranes utilize two acyltransferases that transfer β-hydroxymyristate from ACP to the 3-hydroxyl of UDP-N-acetyl glucosamine (LpxA) or to the amino group of UDP-O-acyl glucosamine (LpxD) . These acyltransferases have a higher affinity for the β-hydroxymyristoyl-ACP than the FAS II enzymes and thus efficiently remove the intermediate from the biosynthetic pathway. Evidence for this comes from the observation that a suppressor of lpxA mutants is mapped to fabZ, the dehydratase that competes with these acyltransferases for the β-hydroxymyristoyl-ACP intermediate (Mohan et al. 1994) . The ability of the acyltransferases to bind β-hydroxymyristoyl-ACP with high affinity is thought to be due to the presence of a hydrocarbon ruler that precisely binds the acyl moiety (Wyckoff et al. 1998 ). FabZ does not compete successfully with LpxA and LpxD for β-hydroxymyristoyl-ACP because this enzyme utilizes all chain lengths of pathway intermediates (Heath and Rock 1996c) . The crystal structure of FabZ is one of the missing pieces in the structural biology of the FAS II pathway, and obtaining this structure will contribute to the understanding of the substrate specificity of this enzyme.
Genes required for branched-chain fatty acid biosynthesis
The incredible diversity of bacterial lipid structure insures that there are exceptions to any rule, but straight-chain SFA and UFA are generally found in Gram-negative bacteria, like the E. coli model, whereas Gram-positive bacteria have branched-chain fatty acids. Major exceptions to this rule are the members of the streptococci, which are Gram-positive bacteria that produce straight-chain SFA and UFA. Straightchain fatty acids include palmitic, stearic, hexadecenoic, octadecenoic, cyclopropane derivatives of the monoenes, 10-methylhexadecanoic, and 2-or 3-hydroxy fatty acids. Branched-chain fatty acids include iso-, anteiso-, and ω-alicyclic fatty acids with or without modification (unsaturation and hydroxylation). Bacteria produce these different acyl group structures using essentially the same set of type II enzymes, and B. subtilis has been extensively studied to understand the differences in the two systems (Kaneda 1963 (Kaneda , 1991 . Metabolic labeling experiments showed that branched-chain fatty acids arise from branched-chain amino acid metabolism, which produces short-chain branched acylCoAs such as isobutyric, isovaleric, and 2-methylbutryric acids that are used as primers for type II fatty acid synthesis in place of acetyl-CoA. Metabolic labeling and feeding experiments with B. subtilis have shown that these branched-chain CoA thioesters are essential intermediates in branched-chain fatty acid biosynthesis and arise from iso-and anteisobranched α-keto acids derived from the biosynthesis pathways for the amino acids valine, leucine, and isoleucine (Willecke and Pardee 1971) .
There are three differences between the E. coli model and B. subtilis that account for branched-chain fatty acid formation. First, B. subtilis lacks the fabA and fabB genes that are essential for UFA synthesis in E. coli, and this property accounts for the absence of UFA production by the Grampositive type II system. Bacillus subtilis does make UFA under conditions of cold stress, but the synthesis of these UFA occurs via a cold-induced oxygen-dependent desaturase that uses existing phospholipids as substrate to introduce a double bond at the 5 position of the acyl chains (Cybulski et al. 2002; Aguilar et al. 2001; Altabe et al. 2003) . Second, the substrate specificity of FabH is a determining factor in branched-chain fatty acid biosynthesis. Acetyl-CoA is the FabH substrate in the E. coli pathway for straight-chain fatty acids (Fig. 1) . The FabH enzyme is highly selective for acetyl-CoA. Propionyl-CoA is also a substrate, but butyrylCoA and branched-chain acyl-CoAs are not (Heath and Rock 1996a; Choi et al. 2000a ). The basis for this substrate specificity is easily discerned from the examination of the crystal structures of E. coli FabH, which show a restricted substrate binding pocket that cannot accommodate a fourcarbon acyl chain (Davies et al. 2000; Qiu et al. 2001) . In contrast, the FabH enzymes from organisms that produce branched-chain fatty acids efficiently utilize butyryl-CoA, isobutyryl-CoA, and isovaleryl-CoA (Han et al. 1998 FabH of M. tuberculosis is selective for long-chain acylCoAs (Choi et al. 2000b) , and the X-ray structure of this enzyme reveals a large, hydrophobic acyl binding pocket adjacent to the active site cysteine (Scarsdale et al. 2001 ). The branched-chain FabH enzymes are predicted to have a substrate binding pocket intermediate between the E. coli and M. tuberculosis isoforms, and obtaining a high-resolution structure for this class of FabH enzymes will be important for understanding the differences in substrate specificity.
There are two FabH homologs in B. subtilis, and both enzymes preferentially use branched-chain fatty acids as primers to synthesize fatty acid in vitro (Kunst et al. 1997 ). The Streptomyces glaucescens FabH enzyme can efficiently utilize iso and anteiso precursors and is thought to be responsible for initiating branched-chain fatty acid synthesis in this organism (Han et al. 1998 ). Branched-chain fatty acid biosynthesis can be reconstituted in vitro by using bsFabH1 or bsFabH2 with other E. coli FAS II fatty synthases, illustrating that FabH is a determining factor in branched-chain fatty acid biosynthesis. However, it is clear that FabH itself is not solely responsible. Expression of fabH genes that utilize branched-chain precursors in E. coli does not lead to the production of branched-chain fatty acids by this organism (Choi et al. 2000a; Smirnova and Reynolds 2001) . Thus, the ability of these FabH enzymes to function is limited by the availability of precursors.
The third requirement for branched-chain fatty acid synthesis is the expression of a special branched-chain α-keto acid (BCKA) decarboxylase to generate the branched-chain acyl-CoA primers from α-keto acids derived from amino acid precursors (Fig. 3) . The idea that the supply of precursors plays a role in branched-chain fatty acid synthesis arose from feeding B. subtilis with different branched-chain acids or butyrate and finding a corresponding increase in branched-chain or straight-chain fatty acids (Kaneda 1963 ). The addition of exogenous leucine or valine to cultures of S. glaucescens results in an increase in the corresponding branched-chain fatty acids derived from these amino acids (Han et al. 1998) , confirming that these acyl moieties arise from amino acid precursors. The relevant decarboxylase has been most extensively studied in B. subtilis. This enzyme is closely related to the pyruvate dehydrogenase complex but has distinct biochemical properties and substrate specificity (Oku and Kaneda 1988) . Specifically, the affinity of the complex for BCKAs is >100-fold higher than that of pyruvate dehydrogenase. A B. subtilis mutant (bfm) that requires the addition of branched-chain precursors to the medium for growth is deficient in BCKA decarboxylase (Willecke and Pardee 1971; Boudreaux et al. 1981) . A Streptomyces avermitilis mutant unable to produce the branched-chain precursors lacked the BCKA decarboxylase (termed AcdH) (Cropp et al. 2000; Zhang et al. 1999) . Unlike the B. subtilis mutant, the S. avermitilis mutant did not have an obligatory requirement for supplementation with branched-chain precursors but rather switched the product distribution of the pathway to generate significant amounts of UFA (Cropp et al. 2000) . It will be important to determine if the mechanism that underlies this switch in the product distribution of FAS II is an intrinsic property of the synthase or if altered gene expression is required for the change.
The B. subtilis decarboxylase genes involved in branchedchain synthesis were cloned by complementation of the bfm mutant and its primary structure characterized (Wang et al. 1993) . There are three genes that comprise the bfm locus. The first two genes correspond to the α and β subunits of the E1 component of the complex that requires thiamine pyrophosphate and catalyzes the decarboxylation of the α-keto acid and formation of the covalent thiamine pyrophosphate adduct, 3-methyl-2-oxobutanoate (Fig. 3) . The third gene corresponds to the E2 component (dihydrolipoyl transacylase), which transfers the thiamine pyrophosphate adduct to the bound lipoic acid cofactor and releases the acyl-CoA product. The NAD + -dependent dihydrolipoyl dehydrogenase (E3) protein is required to oxidize the lipoic acid and reform the catalytically competent dehydrogenase complex. There is a single gene for E3 in B. subtilis that is shared between BCKA and pyruvate dehydrogenase. The condensation of malonyl-ACP with the branched-chain fatty acyl-CoA is accomplished by FabH. The components of the core FAS II elongation system extend these products to produce the constellation of branched-chain fatty acids in the membrane.
The structure of the fatty acid components is the major determinant of membrane biophysical properties. In the E. coli model system, this property is altered by modifying the UFA to SFA ratio, and usually, SFA are found at the 1 position of the glycerophospholipids and UFA at the 2 position . In B. subtilis, membrane fluidity control is exerted by altering the ratio of iso and anteiso fatty acids (Kaneda 1991) . Phospholipids with anteiso branched-chain fatty acids have lower melting points than those with the corresponding iso acids Mantsch et al. 1985 Mantsch et al. , 1987 . Thus, anteiso fatty acids fulfill the role of UFA in bacteria that have only branched-chain fatty acids, and accordingly, anteiso acyl groups are found primarily at the 2 position of the phospholipids (Kaneda 1991) . Also, bacteria grown at low temperatures have increased amounts of anteiso fatty acids compared with the same bacteria grown at higher temperatures. Although this information has been known for decades, the biochemical mechanism responsible for adjusting the ratio of iso to anteiso fatty acids is unknown. BCKA decarboxylase has not been tested to determine if its substrate specificity changes with temperature. Alternatively, the regulation could lie at the level of FabH. Bacillus subtilis has two FabH genes, and although these proteins are very highly related, there are some differences in their substrate specificities. bsFabH1 has a slight preference for the anteiso precursor, while bsFabH2 is more active with acetyl-CoA and iso precursors (Choi et al. 2000a) . Whether these small differences are exacerbated by temperature and account for the observed compositional changes must be tested using genetic approaches.
Regulation of fatty acid biosynthesis
Fatty acid biosynthesis is coordinately regulated with phospholipid synthesis, macromolecular synthesis, and Fig. 3 . Branched fatty acid biosynthesis. Branched chain amino acid precursors (leucine as an example) are converted to the corresponding α-keto acids by either a transaminase or NAD + -dependent dehydrogenase (DH). The decarboxylation of α-keto acids is catalyzed by the 3-methyl-2-oxobutanoate dehydrogenase complex. The E1 component decarboxylates the substrate and forms a covalent thiamine pyrophosphate (TPP) adduct. Dihydrolipoyl transacylase (E2) transfers the TPP adduct to the bound lipoic acid cofactor, exchanges the lipoate thioester with CoA, and releases the acyl-CoA product. The NAD + -dependent dihydrolipoyl dehydrogenase (E3) is required to oxidize the lipoic acid and reform the catalytically competent dehydrogenase complex. A condensation of malonyl-ACP with branched-chain fatty acyl-CoA by FabH initiates cycles of branched-chain fatty acid biosynthesis. growth as part of the response to changes in the environment. Many regulatory processes, such as temperature control of composition and coordination of phospholipid and fatty acid synthesis, are rapid responses of the integrated biochemical network and do not involve changes in gene expression Tsuji et al. 2001; Heath et al. 2002) . The clearest example of acute pathway regulation is the feedback inhibition of FabH Rock 1996a, 1996b) , FabI (Heath and Rock 1996b) , and acetyl-CoA carboxylase (Davis and Cronan 2001) by long-chain acyl-ACP end-products of FAS II. An important recent development is the identification and characterization of transcription factors that modify the pathway activity by either altering the levels of a few important genes or controlling a global adjustment in the expression levels of the entire pathway. There is a lot more work that needs to be done in this exciting area, and the current status of the field is summarized in Table 1 . The fatty acid degradation regulator (FadR) and FabR homologs are found in many Gram-negative bacteria, and these factors alter product composition by controlling the expression of the key genes in UFA biosynthesis, fabA and fabB. The fatty acid and phospholipid biosynthesis regulator (FapR) and fatty acid biosynthesis transcriptional regulator (FabT) are restricted to Gram-positive organisms, and these factors are thought to simultaneously control the expression of all of the genes in the FAS II pathway.
FadR was first discovered as a repressor of fatty acid β-oxidation genes in E. coli through the analysis of a mutation that results in the constitutive induction of the β-oxidation enzymes (Overath and Raufuss 1967; Overath et al. 1969) . Mutations in FadR allow the bacteria to grow on both medium-chain (8-12) and long-chain (≥14) fatty acids, while the wild-type cells only grow on long-chain fatty acids. The second role of FadR arose from a more subtle observation that fabA(Ts) fadR double mutants were unable to grow at the permissive temperature without a UFA supplement (Nunn et al. 1983) . Also, fadR strains were unusually sensitive to a specific FabA inhibitor, which suggested that the FabA levels in fadR strains are lower than normal . These data are consistent with FadR functioning as an activator of UFA synthesis, and it was soon demonstrated that FadR binds to the -40 region of the fabA gene and activates the transcription of this gene (Henry and Cronan 1991; Henry and Cronan 1992) . FadR is also a positive regulator of the fabB gene (Campbell and Cronan 2001b) . FadR is released from its DNA binding sites by long-chain acyl-CoAs, which bind to the carboxyl terminus of the protein and release the amino terminal winged helix domain from the DNA (van Aalten et al. 2000 (van Aalten et al. , 2001 Xu et al. 2001) . Recently, FadR was found to negatively regulate the fadJ and fadI genes that are involved in a novel anaerobic β-oxidation pathway (Campbell et al. 2003) . Thus, FadR has the remarkable property of coordinating fatty acid degradation and biosynthesis by acting as a repressor of β-oxidation genes and an activator of the two genes required for UFA synthesis (Cronan and Subrahmanyam 1998) .
FabR is a second Gram-negative regulator implicated in the regulation of fatty acid biosynthesis by the application of a computational "phylogenetic footprinting" method (McCue et al. 2001) , which was developed to identify transcription factor binding sites in bacterial genomes. The pro- . The mRNA for two fatty acid biosynthesis genes, fabA and fabB, increased in the fabR null strains, suggesting that FabR is a repressor of both loci. Thus, UFA synthesis in E. coli is regulated by a combinatorial lock on the promoters of the key genes consisting of the transcriptional activator FadR and the transcriptional repressor FabR. The application of the phylogenetic footprinting approach identified FabR homologs and related DNA binding motifs in Gram-negative bacteria that contain both the fabA and fabB genes (McCue et al. 2001) , indicating that most Gram-negative organisms utilize a mechanism for UFA synthesis and regulation similar to that in E. coli. A major gap in our understanding of this system is that the ligand, or mechanism, for the regulation of FabR binding to these promoters remains a mystery. The FapR transcriptional regulator controls the expression of the FAS II pathway in Gram-positive bacteria. Bacillus subtilis responds to antibiotic inhibitors of the FAS II condensing enzyme by upregulating the expression of the fabHfabF operon (Schujman et al. 2001 ). This observation instigated a search for a transcription factor that controls the expression of this operon, and FapR was purified by affinity chromatography using the B. subtilis fabH1 promoter region and identified from its N-terminal sequence (Schujman et al. 2003) . The fapR deletion strain has increased expression levels of all FAS II genes, indicating that it functions as a global repressor of the entire set of FAS II genes. The FapR null cells have a cold-sensitive phenotype, which may relate to the abnormally long chain lengths of fatty acids produced by the hyperinduced FAS II in these strains. Also, FapR is responsible for the upregulation of FAS II genes in response to antibiotics that block the pathway. The key fatty acid biosynthetic intermediate, malonyl-CoA, is proposed as the FapR ligand; however, the direct demonstration of modulation of FapR DNA binding ability by malonyl-CoA will be needed to confirm this hypothesis. FapR is conserved in many Gram-positive bacteria, and the regulatory circuit defined in B. subtilis can probably be extended to embrace these organisms also.
Other Gram-positive bacteria have a different transcription factor strongly predicted to regulate the FAS II cluster, FabT. This factor is located in the cluster of FAS II genes in Grampositive bacteria, such as Streptococcus, Enterococcus, Clostridium, and Lactococcus Osterman and Overbeek 2003) . FabT belongs to the MarR family of transcriptional repressor whose DNA binding properties are modified by small molecule ligands (Alekshun et al. 2000 (Alekshun et al. , 2001 . Bioinformatic analysis reveals the presence of conserved DNA palindromes in the promoter regions of several genes in the FAS II cluster . In S. pneumoniae, the palindromes locate prior to fabM, fabT, and fabK, and we propose that FabT autoregulates its own expression and controls the two key enzymes in UFA synthesis, FabK and FabM. Indeed, purified FabT binds to these DNA sequences in vitro (Y.-J. Lu, Y.-M. Zhang, and C.O. Rock, unpublished observations). Interestingly, in Enterococcus, which does not contain FabM for UFA synthesis, the FabT palindromes are found not only in the large FAS II cluster but also in the three-gene cluster ( fabI, fabZ, and fabF) that is hypothesized to support UFA synthesis (see above). At present, it is not clear whether FabT has the same biological role as FabR in the regulation of genes involved in UFA synthesis or whether it is a global regulator of FAS II. The study of FabT is in its infancy, and the ligand or mechanism that controls the DNA binding properties of FabT, as well as the number of genes under its control, is an open question that will surely be the focus of future research.
Conclusions
The bacterial FAS II uses a common set of tools to carry out the elongation of acyl chains. Minor additions or subtractions from this basic scheme are used to produce the diversity of fatty acid structures seen in the bacterial world. Most of the genes and enzymes required for these metabolic transformations are known and future work will focus on understanding the regulatory mechanisms that control the expression of these genes in Gram-negative and Gram-positive bacteria. Understanding the differences between them is important not only from a basic research viewpoint but also because FAS II is emerging as a major target for the development of novel antibacterial agents (Heath et al. 2001b (Heath et al. , 2001a Campbell and Cronan 2001a) . Defining the species-specific differences in the pathway is critical for selecting appropriate targets and predicting the spectrum of activity of drugs developed against FAS II targets.
